Massimo Volpe

All Stories

Weekly Journal Scan: a ‘thousand-mile’ journey in obesity-related heart failure treatment begins with a few STEPs

Article • European Heart Journal, July 2024, Oxford University Press (OUP)

Massimo Volpe
Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial

Article • European Heart Journal, July 2024, Oxford University Press (OUP)

Massimo Volpe
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention

Article • Cardiovascular Research, July 2024, Oxford University Press (OUP)

Massimo Volpe
“The impact of the COVID-19 pandemic on research activities: A survey of the largest Italian academic community”

Article • PLoS ONE, June 2024, PLOS

Massimo Volpe
Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk

Article • Diagnostics, June 2024, MDPI AG

Massimo Volpe
Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?

Article • European Heart Journal, June 2024, Oxford University Press (OUP)

Massimo Volpe
Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study

Article • Metabolites, June 2024, MDPI AG

Massimo Volpe
Weekly Journal Scan: a novel RNA-based approach to the treatment of hypertriglyceridaemia

Article • European Heart Journal, June 2024, Oxford University Press (OUP)

Massimo Volpe
Discontinuation of renin–angiotensin system inhibitors brings no benefits in severe chronic kidney disease

Article • European Heart Journal, May 2024, Oxford University Press (OUP)

Massimo Volpe
Weekly journal scan: every breath you take, air pollution impacts your cardiovascular health

Article • European Heart Journal, April 2024, Oxford University Press (OUP)

Massimo Volpe
Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction—broader paths for secondary prevention

Article • European Heart Journal, April 2024, Oxford University Press (OUP)

Massimo Volpe
Obesity: an overlooked player in cardiological practice and the need for urgent action

Article • European Heart Journal, April 2024, Oxford University Press (OUP)

Massimo Volpe
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction

Article • European Heart Journal, March 2024, Oxford University Press (OUP)

Massimo Volpe
Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysis

Article • Cardiovascular Research, March 2024, Oxford University Press (OUP)

Massimo Volpe
Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor

Article • European Heart Journal, March 2024, Oxford University Press (OUP)

Massimo Volpe
Lowering dietary sodium intake to reduce blood pressure: cum grano salis

Article • European Heart Journal, February 2024, Oxford University Press (OUP)

Massimo Volpe
Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments

Article • High Blood Pressure & Cardiovascular Prevention, February 2024, Springer Science + Business Media

Massimo Volpe
A new RNA-interference based strategy is associated with mild beneficial effects in patients with heart failure due to cardiac amyloidosis

Article • European Heart Journal, January 2024, Oxford University Press (OUP)

Massimo Volpe
β1-Adrenergic receptor stimulation modulates immune response in cancer: a role for β-blockers in antineoplastic treatment?

Article • European Heart Journal, January 2024, Oxford University Press (OUP)

Massimo Volpe
The Emerging Role of Prediabetes and Its Management: Focus on l-Arginine and a Survey in Clinical Practice

Article • High Blood Pressure & Cardiovascular Prevention, December 2023, Springer Science + Business Media

Massimo Volpe
Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients

Article • European Heart Journal, November 2023, Oxford University Press (OUP)

Massimo Volpe
Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?

Article • European Heart Journal, November 2023, Oxford University Press (OUP)

Massimo Volpe
More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostat

Article • European Heart Journal, November 2023, Oxford University Press (OUP)

Massimo Volpe
Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?

Article • European Heart Journal, October 2023, Oxford University Press (OUP)

Massimo Volpe
Light the FIRE of revascularization in older patients with myocardial infarction

Article • European Heart Journal, September 2023, Oxford University Press (OUP)

Massimo Volpe
The promise of a new orally active body weight reducer

Article • European Heart Journal, August 2023, Oxford University Press (OUP)

Massimo Volpe
The revolution of beat-to-beat wireless bidirectional communication between intra-cardiac devices

Article • European Heart Journal, August 2023, Oxford University Press (OUP)

Massimo Volpe
New evidence supporting haemodynamics-guided remote management of congestion in heart failure

Article • European Heart Journal, July 2023, Oxford University Press (OUP)

Massimo Volpe
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals

Article • Nutrition Metabolism and Cardiovascular Diseases, July 2023, Elsevier

Massimo Volpe
Artificial intelligence in echocardiography: a better alternative to the human eye?

Article • European Heart Journal, June 2023, Oxford University Press (OUP)

Massimo Volpe
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?

Article • European Heart Journal, June 2023, Oxford University Press (OUP)

Massimo Volpe
Coffee drinking and cardiac ectopic beats: Black or White?

Article • European Heart Journal, May 2023, Oxford University Press (OUP)

Massimo Volpe
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients?

Article • European Heart Journal, April 2023, Oxford University Press (OUP)

Massimo Volpe
Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention

Article • European Heart Journal, April 2023, Oxford University Press (OUP)

Massimo Volpe
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention

Article • High Blood Pressure & Cardiovascular Prevention, April 2023, Springer Science + Business Media

Massimo Volpe
TRANSFORM-HF closes the loop on diuretic therapy in heart failure

Article • European Heart Journal, March 2023, Oxford University Press (OUP)

Massimo Volpe
Improving care for heart failure patients by COACHing clinicians to use decision-support tools

Article • European Heart Journal, March 2023, Oxford University Press (OUP)

Massimo Volpe
The ‘cold case’ of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?

Article • European Heart Journal, February 2023, Oxford University Press (OUP)

Massimo Volpe
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season?

Article • European Heart Journal Supplements, February 2023, Oxford University Press (OUP)

Massimo Volpe
Influenza vaccine for heart failure patients in low- and middle-income countries: another piece in the puzzle

Article • European Heart Journal, January 2023, Oxford University Press (OUP)

Massimo Volpe
Endocrine functions of the heart: from bench to bedside

Article • European Heart Journal, December 2022, Oxford University Press (OUP)

Massimo Volpe
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension

Article • European Heart Journal, December 2022, Oxford University Press (OUP)

Massimo Volpe
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE

Article • European Heart Journal, December 2022, Oxford University Press (OUP)

Massimo Volpe
Prevention of cardiorenal damage: importance of albuminuria

Article • European Heart Journal, December 2022, Oxford University Press (OUP)

Massimo Volpe
Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of β blockers

Article • European Heart Journal, December 2022, Oxford University Press (OUP)

Massimo Volpe
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges

Article • European Heart Journal, November 2022, Oxford University Press (OUP)

Massimo Volpe
Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Massimo Volpe
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide?

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Massimo Volpe
SGLT2 inhibitors DELIVER benefits in heart failure independently of ejection fraction and diabetes: end of the line or need for new studies?

Article • European Heart Journal, September 2022, Oxford University Press (OUP)

Massimo Volpe
Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape

Article • European Heart Journal, September 2022, Oxford University Press (OUP)

Massimo Volpe
One-shot thrombolysis for the management of acute ischaemic stroke

Article • European Heart Journal, August 2022, Oxford University Press (OUP)

Massimo Volpe
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation

Article • European Heart Journal, August 2022, Oxford University Press (OUP)

Massimo Volpe
Deciphering a decision support tool (CoDE-HF) to improve the diagnosis of acute heart failure

Article • European Heart Journal, July 2022, Oxford University Press (OUP)

Massimo Volpe
Diastolic Blood Pressure Levels and Cardiovascular Risk in Elderly Women: The Need for a Personalized Approach

Article • American Journal of Hypertension, July 2022, Oxford University Press (OUP)

Massimo Volpe
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations

Article • Vascular Health and Risk Management, July 2022, Taylor & Francis

Massimo Volpe
The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis

Article • European Heart Journal, June 2022, Oxford University Press (OUP)

Massimo Volpe
Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up

Article • European Heart Journal, June 2022, Oxford University Press (OUP)

Massimo Volpe
Treatment of mild hypertension improves pregnancy outcomes

Article • European Heart Journal, May 2022, Oxford University Press (OUP)

Massimo Volpe
Detection of risk factors in childhood: a new perspective in cardiovascular prevention

Article • European Heart Journal, May 2022, Oxford University Press (OUP)

Massimo Volpe
The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain?

Article • European Heart Journal, April 2022, Oxford University Press (OUP)

Massimo Volpe
SARS-CoV-2 infection markedly increases long-term cardiovascular risk

Article • European Heart Journal, April 2022, Oxford University Press (OUP)

Massimo Volpe
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials

Article • European Heart Journal, March 2022, Oxford University Press (OUP)

Massimo Volpe
Correction to: Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention

Article • High Blood Pressure & Cardiovascular Prevention, March 2022, Springer Science + Business Media

Massimo Volpe
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate

Article • European Heart Journal, February 2022, Oxford University Press (OUP)

Massimo Volpe
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugs

Article • European Heart Journal, February 2022, Oxford University Press (OUP)

Massimo Volpe
Myocarditis after BNT162b2 mRNA SARS-CoV-2 vaccine: low incidence and mild severity

Article • European Heart Journal, January 2022, Oxford University Press (OUP)

Massimo Volpe
Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention

Article • High Blood Pressure & Cardiovascular Prevention, January 2022, Springer Science + Business Media

Massimo Volpe
Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes

Article • European Heart Journal, January 2022, Oxford University Press (OUP)

Massimo Volpe
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction

Article • European Heart Journal, December 2021, Oxford University Press (OUP)

Massimo Volpe
Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Article • High Blood Pressure & Cardiovascular Prevention, December 2021, Springer Science + Business Media

Massimo Volpe
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted Approach

Article • Hypertension, December 2021, Wolters Kluwer Health

Massimo Volpe
Age-independent benefits of blood pressure lowering: are they applicable to all patients?

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Massimo Volpe
Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Massimo Volpe
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Massimo Volpe
Computed tomography coronary angiography in acute chest pain: an excellent diagnostic tool with poor added value on clinical outcomes

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Massimo Volpe
Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions?

Article • High Blood Pressure & Cardiovascular Prevention, November 2021, Springer Science + Business Media

Massimo Volpe
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Massimo Volpe
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Massimo Volpe
Another STEP towards tighter control of blood pressure in the elderly

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Massimo Volpe
The EMPEROR-Preserved study: end of the search for the “Phoenix” or beginning of a new season for trials in heart failure with preserved ejection fraction

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Massimo Volpe
The cardiovascular benefits of statins outweigh adverse effects in primary prevention: results of a large systematic review and meta-analysis

Article • European Heart Journal, September 2021, Oxford University Press (OUP)

Massimo Volpe
An inflammatory ageing clock to detect cardiovascular and other age-related diseases: a new approach to preventive medicine

Article • European Heart Journal, September 2021, Oxford University Press (OUP)

Massimo Volpe
Repurposing Cardio-Metabolic Drugs to Fight Covid19

Article • High Blood Pressure & Cardiovascular Prevention, September 2021, Springer Science + Business Media

Massimo Volpe
A ‘Once-and-Done’ Approach to the Lifelong Reduction of Elevated Cholesterol

Article • European Heart Journal, August 2021, Oxford University Press (OUP)

Massimo Volpe
Hypertension Management and Control in Italy: A Real-World Survey in Elderly Patients

Article • High Blood Pressure & Cardiovascular Prevention, August 2021, Springer Science + Business Media

Massimo Volpe
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?

Article • European Heart Journal, August 2021, Oxford University Press (OUP)

Massimo Volpe
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes

Article • European Heart Journal, August 2021, Oxford University Press (OUP)

Massimo Volpe
Exploring RNA biomarkers in patients with acute myocarditis

Article • European Heart Journal, August 2021, Oxford University Press (OUP)

Massimo Volpe
Worsening of risk factor control in US diabetic patients: a call to action

Article • European Heart Journal, July 2021, Oxford University Press (OUP)

Massimo Volpe
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile

Article • European Heart Journal, July 2021, Oxford University Press (OUP)

Massimo Volpe
A SPRINT towards tighter control of blood pressure in hypertension

Article • European Heart Journal, June 2021, Oxford University Press (OUP)

Massimo Volpe
The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk

Article • European Heart Journal, June 2021, Oxford University Press (OUP)

Massimo Volpe
Glycaemicindex: an emergent global silent killer for the heart

Article • European Heart Journal, June 2021, Oxford University Press (OUP)

Massimo Volpe
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities’ impact on cardiovascular outcomes in US and UK adults: a call for action for social cardiology

Article • European Heart Journal, June 2021, Oxford University Press (OUP)

Massimo Volpe
Vulnerable non-culprit coronary plaques: are they worth treating?

Article • European Heart Journal, May 2021, Oxford University Press (OUP)

Massimo Volpe
Hypertension, a Moving Target in COVID-19

Article • Circulation Research, April 2021, Wolters Kluwer Health

Massimo Volpe
Cryoblation as first-line treatment of new-onset atrial fibrillation?

Article • European Heart Journal, March 2021, Oxford University Press (OUP)

Massimo Volpe
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company

Article • Journal of Human Hypertension, March 2021, Springer Science + Business Media

Massimo Volpe
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients

Article • High Blood Pressure & Cardiovascular Prevention, March 2021, Springer Science + Business Media

Massimo Volpe
The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending

Article • European Heart Journal, March 2021, Oxford University Press (OUP)

Massimo Volpe
Glucocorticoids in patients with immune-mediated inflammatory diseases: a neglected cardiovascular risk factor

Article • European Heart Journal, February 2021, Oxford University Press (OUP)

Massimo Volpe
Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database

Article • Journal of Human Hypertension, February 2021, Springer Science + Business Media

Massimo Volpe
PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancer

Article • European Heart Journal, February 2021, Oxford University Press (OUP)

Massimo Volpe
Iron heart

Article • European Heart Journal, January 2021, Oxford University Press (OUP)

Massimo Volpe
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, January 2021, Springer Science + Business Media

Massimo Volpe
The REDUCE-IT verdict on eicosapentaenoic acid and cardiovascular outcome challenged with STRENGTH

Article • European Heart Journal, December 2020, Oxford University Press (OUP)

Massimo Volpe
Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problems

Article • European Heart Journal, December 2020, Oxford University Press (OUP)

Massimo Volpe
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists

Article • Cardiovascular Research, November 2020, Oxford University Press (OUP)

Massimo Volpe
Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors?

Article • European Heart Journal, November 2020, Oxford University Press (OUP)

Massimo Volpe
The second life of the ambiguous angiotensin-converting enzyme 2 as a predictive biomarker for cardiometabolic diseases and death

Article • European Heart Journal, November 2020, Oxford University Press (OUP)

Massimo Volpe
Out-of-Hospital Cardiac Arrest: Handle With Care–Comment on the Resuscitation Outcomes Consortium Cardiac Epidemiologic Registry

Article • European Heart Journal, November 2020, Oxford University Press (OUP)

Massimo Volpe
Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data

Article • European Heart Journal, October 2020, Oxford University Press (OUP)

Massimo Volpe
Age and Multimorbidity Predict Death Among COVID-19 Patients

Article • Hypertension, August 2020, Wolters Kluwer Health

Massimo Volpe
Genes and hypertension: stepping into the secret through the arterial wall

Article • European Heart Journal, July 2020, Oxford University Press (OUP)

Massimo Volpe
Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review

Article • High Blood Pressure & Cardiovascular Prevention, May 2020, Springer Science + Business Media

Massimo Volpe
Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?

Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2020, Oxford University Press (OUP)

Massimo Volpe
New approach to blood pressure control: Triple combination pill

Article • Trends in Cardiovascular Medicine, February 2020, Elsevier

Massimo Volpe
Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, January 2020, Springer Science + Business Media

Massimo Volpe
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits

Article • Internal and Emergency Medicine, December 2019, Springer Science + Business Media

Massimo Volpe
Conventional and new electrocardiographic criteria for hypertension‐mediated cardiac organ damage: A narrative review

Article • Journal of Clinical Hypertension, November 2019, Wiley

Massimo Volpe
Antihypertensive drugs and the risks of cancer: More fakes than facts

Article • European Journal of Preventive Cardiology, October 2019, SAGE Publications

Massimo Volpe
Excess of dyslipidemia in low income countries: The case of Colombia in the PURE study

Article • International Journal of Cardiology, September 2019, Elsevier

Massimo Volpe
Arterial hypertension in cancer: The elephant in the room

Article • International Journal of Cardiology, April 2019, Elsevier

Massimo Volpe
Natriuretic peptides in heart failure: Current achievements and future perspectives

Article • International Journal of Cardiology, April 2019, Elsevier

Massimo Volpe
Tales in Cardiology

Article • European Heart Journal, March 2019, Oxford University Press (OUP)

Massimo Volpe
The “hidden side of the moon” in hypertension: When and why is dangerous low diastolic blood pressure?

Article • International Journal of Cardiology, February 2019, Elsevier

Massimo Volpe
Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know

Article • High Blood Pressure & Cardiovascular Prevention, January 2019, Springer Science + Business Media

Massimo Volpe
Response to letter from Madias regarding our article “Admission heart rate and in-hospital course of patients with Takotsubo syndrome”

Article • International Journal of Cardiology, January 2019, Elsevier

Massimo Volpe
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan

Article • Advances in Therapy, December 2018, Springer Science + Business Media

Prof. Stefano Omboni, Massimo Volpe
Admission heart rate and in-hospital course of patients with Takotsubo syndrome

Article • International Journal of Cardiology, December 2018, Elsevier

Massimo Volpe
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan

Article • Cardiovascular Therapeutics, November 2018, Wiley

Prof. Stefano Omboni, Massimo Volpe
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc

Article • International Journal of Cardiology, October 2018, Elsevier

Massimo Volpe
Role of oxidative stress in the process of vascular remodeling following coronary revascularization

Article • International Journal of Cardiology, October 2018, Elsevier

Massimo Volpe
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy

Article • High Blood Pressure & Cardiovascular Prevention, September 2018, Springer Science + Business Media

Massimo Volpe
What's HIV got to do with cardiovascular disease?

Article • International Journal of Cardiology, August 2018, Elsevier

Massimo Volpe
Lifestyle and cardiovascular disease: Barefooting through the guidelines

Article • International Journal of Cardiology, July 2018, Elsevier

Massimo Volpe
Search of multiple markers of organ damage for better cardiovascular risk stratification in hypertension: Role of “SHATS” syndrome in the clinical practice

Article • International Journal of Cardiology, July 2018, Elsevier

Massimo Volpe
Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)—Lessons learned for losartan: An “old dog playing good tricks”

Article • Journal of Clinical Hypertension, June 2018, Wiley

Massimo Volpe
Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database

Article • Journal of Clinical Hypertension, April 2018, Wiley

Giuliano Tocci, Massimo Volpe
Inflammatory residual risk: An emerging target to reduce cardiovascular disease?

Article • Clinical Cardiology, April 2018, Wiley

Massimo Volpe
Is early and fast blood pressure control important in hypertension management?

Article • International Journal of Cardiology, March 2018, Elsevier

Massimo Volpe
Epigenetics and cardiovascular regenerative medicine in the elderly

Article • International Journal of Cardiology, January 2018, Elsevier

Massimo Volpe
Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform

Article • High Blood Pressure & Cardiovascular Prevention, October 2017, Springer Science + Business Media

Massimo Volpe
Calcium Channel Blockers for the Clinical Management of Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, October 2017, Springer Science + Business Media

Massimo Volpe
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corr...

Article • Clinical Interventions in Aging, August 2017, Dove Medical Press

Prof. Stefano Omboni, Massimo Volpe
Cardiovascular disease in women with HIV-1 infection

Article • International Journal of Cardiology, August 2017, Elsevier

Massimo Volpe
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control

Article • High Blood Pressure & Cardiovascular Prevention, June 2017, Springer Science + Business Media

Massimo Volpe
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control

Article • High Blood Pressure & Cardiovascular Prevention, June 2017, Springer Science + Business Media

Massimo Volpe
Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk

Article • High Blood Pressure & Cardiovascular Prevention, June 2017, Springer Science + Business Media

Massimo Volpe
2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document

Article • High Blood Pressure & Cardiovascular Prevention, May 2017, Springer Science + Business Media

Massimo Volpe
Hypertension Across the Atlantic: A Sprint or a Marathon?

Article • High Blood Pressure & Cardiovascular Prevention, April 2017, Springer Science + Business Media

Massimo Volpe
A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat

Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

Massimo Volpe
Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases

Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

Massimo Volpe
Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions

Article • Journal of Cardiovascular Medicine, December 2016, Wolters Kluwer Health

Massimo Volpe
The Age of Nutraceuticals: Exploring New Therapeutic Targets

Article • High Blood Pressure & Cardiovascular Prevention, November 2016, Springer Science + Business Media

Massimo Volpe
New Opportunities for Monitoring Blood Pressure Control and Awareness in the Population: Insights from 12-Year Editions of the World Hypertension Day

Article • High Blood Pressure & Cardiovascular Prevention, October 2016, Springer Science + Business Media

Massimo Volpe
Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database

Article • Journal of Human Hypertension, September 2016, Springer Science + Business Media

Massimo Volpe
T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients

Article • Journal of Cardiovascular Medicine, August 2016, Wolters Kluwer Health

Massimo Volpe
Erythropoiesis‐stimulating agents in heart failure: leave it or re‐take it?

Article • European Journal of Heart Failure, November 2015, Wiley

Massimo Volpe
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Article • Clinical Interventions in Aging, October 2015, Dove Medical Press

Prof. Stefano Omboni, Massimo Volpe
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm

Article • Journal of Electrocardiology, September 2015, Elsevier

Massimo Volpe
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire

Article • Nutrition Metabolism and Cardiovascular Diseases, September 2015, Elsevier

Massimo Volpe
Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis

Article • American Journal of Hypertension, August 2015, Oxford University Press (OUP)

Massimo Volpe
Eligibility for the Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy

Article • Journal of Cardiovascular Electrophysiology, July 2015, Wiley

Massimo Volpe
Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach

Article • High Blood Pressure & Cardiovascular Prevention, July 2015, Springer Science + Business Media

Massimo Volpe
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia

Article • Annals of Internal Medicine, July 2015, American College of Physicians

Massimo Volpe
Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP

Article • Journal of Hypertension, July 2015, Wolters Kluwer Health

Massimo Volpe
Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, July 2015, Springer Science + Business Media

Massimo Volpe
Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty

Article • Catheterization and Cardiovascular Interventions, June 2015, Wiley

Massimo Volpe
Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy

Article • High Blood Pressure & Cardiovascular Prevention, June 2015, Springer Science + Business Media

Massimo Volpe
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Article • New England Journal of Medicine, June 2015, New England Journal of Medicine (NEJM/MMS)

Professor Thomas Munzel or Muenzel, Massimo Volpe
Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire

Article • Internal and Emergency Medicine, May 2015, Springer Science + Business Media

Massimo Volpe
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design: Figure 1

Article • European Heart Journal, May 2015, European Society of Cardiology

Massimo Volpe
Shooting vascular oxidative stress: new hopes for stroke patients?: Figure 1

Article • European Heart Journal, May 2015, European Society of Cardiology

Massimo Volpe
In Memory of Professor John H. Laragh

Article • High Blood Pressure & Cardiovascular Prevention, May 2015, Springer Science + Business Media

Massimo Volpe
An update on hypertensive emergencies and urgencies

Article • Journal of Cardiovascular Medicine, May 2015, Wolters Kluwer Health

Pasquale Palmiero, Massimo Volpe
An easy and reproducible parameter for the assessment of the pressure gradient in patients with aortic stenosis disease: A magnetic resonance study

Article • Journal of Cardiology, May 2015, Elsevier

Massimo Volpe
RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure

Article • Journal of Cardiovascular Electrophysiology, May 2015, Wiley

Massimo Volpe
Cardiovascular Prevention: The Role of Second Generation of Nutraceuticals

Article • High Blood Pressure & Cardiovascular Prevention, April 2015, Springer Science + Business Media

Massimo Volpe
Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

Article • Current Hypertension Reports, April 2015, Springer Science + Business Media

Massimo Volpe
Integrated Preclinical Cardiovascular Prevention: A New Paradigm to Face Growing Challenges of Cardiovascular Disease

Article • American Journal of Cardiovascular Drugs, April 2015, Springer Science + Business Media

Massimo Volpe
Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice

Article • Clinical Cardiology, April 2015, Wiley

Massimo Volpe
mTORC2 Regulates Cardiac Response to Stress by Inhibiting MST1

Article • Cell Reports, April 2015, Elsevier

Massimo Volpe
Managing hypertension after acute coronary syndrome

Article • Journal of Hypertension, April 2015, Wolters Kluwer Health

Massimo Volpe
Hypovitaminosis D and Organ Damage In Patients With Arterial Hypertension: A Multicenter Double Blind Randomised Controlled Trial of Cholecalciferol Supplementation (HYPODD)

Article • High Blood Pressure & Cardiovascular Prevention, March 2015, Springer Science + Business Media

Massimo Volpe
A Novel Electrocardiographic T-Wave Measurement (Tp-Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First-Line Electrocardiographic Evaluation

Article • Journal of Clinical Hypertension, March 2015, Wiley

Giuliano Tocci, Massimo Volpe
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

Article • Circulation Cardiovascular Quality and Outcomes, February 2015, Wolters Kluwer Health

Dr Helena DOMINGUEZ VALL-LAMORA, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello, Massimo Volpe
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys

Article • Journal of Human Hypertension, February 2015, Springer Science + Business Media

Massimo Volpe
Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

Article • Circulation Cardiovascular Genetics, February 2015, Wolters Kluwer Health

Massimo Volpe
Impact of Hypertension on Global Cardiovascular Risk Stratification: Analysis of a Large Cohort of Outpatient Population in Italy

Article • Clinical Cardiology, January 2015, Wiley

Giuliano Tocci, Massimo Volpe
Combination Therapy for the Clinical Management of Hypertension

Article • January 2015, Springer Science + Business Media

Massimo Volpe
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress

Article • International Journal of Molecular Sciences, December 2014, MDPI AG

Massimo Volpe
Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey

Article • Journal of Human Hypertension, December 2014, Springer Science + Business Media

Massimo Volpe
Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes

Article • Clinical Science, December 2014, Portland Press Ltd.

Massimo Volpe
An atypical clinical presentation of renovascular hypertension

Article • International Journal of Cardiology, December 2014, Elsevier

Massimo Volpe
The C2238/αANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells

Article • PLoS ONE, November 2014, PLOS

Massimo Volpe
Calcium Channel Blockers and Hypertension

Article • Journal of Cardiovascular Pharmacology and Therapeutics, November 2014, SAGE Publications

Massimo Volpe
Evaluation of microvascular structure in humans

Article • Journal of Hypertension, November 2014, Wolters Kluwer Health

Massimo Volpe
High natriuretic peptide levels and low DBP

Article • Journal of Hypertension, November 2014, Wolters Kluwer Health

Massimo Volpe
Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients

Article • Hypertension, October 2014, Wolters Kluwer Health

Professor Francesco Semeraro, Massimo Volpe
Natriuretic peptides and cardio-renal disease

Article • International Journal of Cardiology, October 2014, Elsevier

Massimo Volpe
P‐Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension

Article • Annals of Noninvasive Electrocardiology, September 2014, Wiley

Massimo Volpe
Cardiovascular health in migrants

Article • Journal of Cardiovascular Medicine, September 2014, Wolters Kluwer Health

Pasquale Palmiero, Massimo Volpe
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy

Article • Journal of Cardiovascular Electrophysiology, August 2014, Wiley

Massimo Volpe
Impact of the Direct Angiotensin II Type 2 Receptor Stimulation on Renal Function

Article • Hypertension, August 2014, Wolters Kluwer Health

Massimo Volpe
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: Insights from the I-DEMAND study

Article • Nutrition Metabolism and Cardiovascular Diseases, August 2014, Elsevier

Massimo Volpe
Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities

Article • High Blood Pressure & Cardiovascular Prevention, June 2014, Springer Science + Business Media

Massimo Volpe
Prognostic value of serum uric acid

Article • Journal of Hypertension, June 2014, Wolters Kluwer Health

Massimo Volpe
α 2A -Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With Stable Coronary Artery Disease Carrying the Cytochrome P450 2C19*2 Genetic Variant

Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2014, Wolters Kluwer Health

Massimo Volpe
Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes

Article • European Heart Journal, May 2014, European Society of Cardiology

Massimo Volpe
Revisiting the Relationship Between Blood Pressure and Insulin-Like Growth Factor-1

Article • Hypertension, May 2014, Wolters Kluwer Health

Massimo Volpe
Reducing therapeutic inertia to improve blood pressure control

Article • Journal of Hypertension, May 2014, Wolters Kluwer Health

Massimo Volpe
Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

Article • Advances in Therapy, April 2014, Springer Science + Business Media

Massimo Volpe
Erratum to: ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients

Article • High Blood Pressure & Cardiovascular Prevention, March 2014, Springer Science + Business Media

Massimo Volpe
Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases

Article • Clinical Science, March 2014, Portland Press Ltd.

Massimo Volpe
A guide for easy- and difficult-to-treat hypertension

Article • International Journal of Cardiology, March 2014, Elsevier

Massimo Volpe
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension

Article • Hypertension Research, February 2014, Springer Science + Business Media

Massimo Volpe
The p66Shc adapter protein regulates the morphogenesis and epithelial maturation of fetal mouse lungs

Article • AJP Lung Cellular and Molecular Physiology, February 2014, American Physiological Society

Heber Nielsen, Massimo Volpe
ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients

Article • High Blood Pressure & Cardiovascular Prevention, February 2014, Springer Science + Business Media

Massimo Volpe
Angiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter?

Article • ISRN Cardiology, February 2014, Hindawi Publishing Corporation

Massimo Volpe
Polypharmacy in Heart Failure Patients

Article • Current Heart Failure Reports, February 2014, Springer Science + Business Media

Massimo Volpe
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease

Article • Gene, February 2014, Elsevier

Massimo Volpe
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea

Article • Journal of Hypertension, February 2014, Wolters Kluwer Health

Massimo Volpe
NOX4 regulates autophagy during energy deprivation

Article • Autophagy, January 2014, Taylor & Francis

Massimo Volpe
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Article • Circulation Research, January 2014, Wolters Kluwer Health

Massimo Volpe
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators

Article • Journal of Cardiovascular Electrophysiology, January 2014, Wiley

Massimo Volpe
Olmesartan vs. Ramipril in Elderly Hypertensive Patients: Review of Data from Two Published Randomized, Double-Blind Studies

Article • High Blood Pressure & Cardiovascular Prevention, January 2014, Springer Science + Business Media

Prof. Stefano Omboni, Massimo Volpe
New Insights into the Role of Mitochondrial Dynamics and Autophagy during Oxidative Stress and Aging in the Heart

Article • Oxidative Medicine and Cellular Longevity, January 2014, Hindawi Publishing Corporation

Massimo Volpe
Erythropoietin in cardiac disease

Article • Journal of Cardiovascular Medicine, December 2013, Wolters Kluwer Health

Massimo Volpe
National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities

Article • High Blood Pressure & Cardiovascular Prevention, November 2013, Springer Science + Business Media

Massimo Volpe
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?

Article • International Journal of Molecular Sciences, November 2013, MDPI AG

Massimo Volpe
Diagnosis and treatment of resistant hypertension

Article • Blood Pressure, November 2013, Taylor & Francis

Massimo Volpe
Natriuretic peptides in cardiovascular diseases: current use and perspectives

Article • European Heart Journal, November 2013, European Society of Cardiology

Massimo Volpe
Olmesartan in the Treatment of Hypertension in Elderly Patients: a Review of the Primary Evidence

Article • Drugs & Aging, October 2013, Springer Science + Business Media

Massimo Volpe
Clinical Management of Patients with Hypertension and High Cardiovascular Risk

Article • High Blood Pressure & Cardiovascular Prevention, October 2013, Springer Science + Business Media

Massimo Volpe
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

Article • New England Journal of Medicine, October 2013, New England Journal of Medicine (NEJM/MMS)

Professor JOSE F VILELA-MARTIN, Filipa Costa, Professor Yuriy M. Sirenko, Massimo Volpe
Epigenetic signatures and vascular risk in type 2 diabetes: A clinical perspective

Article • Atherosclerosis, October 2013, Elsevier

Massimo Volpe
Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?

Article • Cytokine & Growth Factor Reviews, October 2013, Elsevier

Massimo Volpe
The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot

Article • International Journal of Cardiology, October 2013, Elsevier

Massimo Volpe
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure

Article • Journal of Interventional Cardiac Electrophysiology, September 2013, Springer Science + Business Media

Massimo Volpe
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Article • European Heart Journal, September 2013, European Society of Cardiology

Massimo Volpe
Effects of atorvastatin and rosuvastatin on renal function: A meta-analysis

Article • International Journal of Cardiology, September 2013, Elsevier

Massimo Volpe
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link?

Article • International Journal of Cardiology, September 2013, Elsevier

Massimo Volpe
Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function

Article • International Journal of Cardiology, September 2013, Elsevier

Massimo Volpe
Clinical Management of Resistant Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, August 2013, Springer Science + Business Media

Massimo Volpe
Clinical Management of Coronary Heart Disease in Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, August 2013, Springer Science + Business Media

Massimo Volpe
Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus

Article • JAMA Internal Medicine, August 2013, American Medical Association (AMA)

Massimo Volpe
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage

Article • Journal of Human Hypertension, June 2013, Springer Science + Business Media

Massimo Volpe
2013 ESH/ESC Guidelines for the management of arterial hypertension

Article • European Heart Journal, June 2013, European Society of Cardiology

Professor Thierry C Gillebert, Prof HECTOR BUENO, Professor Yuriy M. Sirenko, Massimo Volpe
Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure

Article • Journal of Hypertension, June 2013, Wolters Kluwer Health

Massimo Volpe
Strategies to improve control of blood pressure in hypertension: moving towards a 70% objective

Article • Expert Review of Cardiovascular Therapy, June 2013, Taylor & Francis

Massimo Volpe
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory: Bringing All the Strands Together

Article • Diabetes, May 2013, American Diabetes Association

Massimo Volpe
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting

Article • European Heart Journal, May 2013, European Society of Cardiology

Massimo Volpe
Pulmonary embolism in pregnancy

Article • Journal of Thrombosis and Thrombolysis, May 2013, Springer Science + Business Media

Massimo Volpe
C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling

Article • Circulation Research, May 2013, Wolters Kluwer Health

Massimo Volpe
The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes

Article • Clinical Science, May 2013, Portland Press Ltd.

Massimo Volpe
Follow-up, study design and outcome parameters

Article • EuroIntervention, May 2013, Europa Digital & Publishing

Massimo Volpe
Simultaneous Takotsubo syndrome in two sisters

Article • International Journal of Cardiology, May 2013, Elsevier

Massimo Volpe
Renin-angiotensin system blockers increase risk of angio-oedema

Article • Evidence-Based Medicine, May 2013, BMJ

Massimo Volpe
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

Article • European Heart Journal, April 2013, European Society of Cardiology

Massimo Volpe
The Pamela Study: Main Findings and Perspectives

Article • Current Hypertension Reports, April 2013, Springer Science + Business Media

Massimo Volpe
NT-proAtrial Natriuretic Peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis

Article • European Journal of Internal Medicine, April 2013, Elsevier

Massimo Volpe
Relation between right and left ventricular function in patients undergoing chronic dialysis

Article • Journal of Cardiovascular Medicine, April 2013, Wolters Kluwer Health

Massimo Volpe
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

Article • JAMA, March 2013, American Medical Association (AMA)

Massimo Volpe
Deletion of the Activated Protein-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction

Article • Circulation, March 2013, Wolters Kluwer Health

Massimo Volpe
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy

Article • High Blood Pressure & Cardiovascular Prevention, March 2013, Springer Science + Business Media

Massimo Volpe
Olmesartan-based therapies

Article • Journal of Hypertension, March 2013, Wolters Kluwer Health

Massimo Volpe
MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery

Article • Heart, February 2013, BMJ

Massimo Volpe
Differential Modulation of Uncoupling Protein 2 in Kidneys of Stroke-Prone Spontaneously Hypertensive Rats Under High-Salt/Low-Potassium Diet

Article • Hypertension, February 2013, Wolters Kluwer Health

Massimo Volpe
Transcatheter Closure of Post-myocardial Infarction Ventricular Septal Rupture

Article • Circulation Cardiovascular Interventions, February 2013, Wolters Kluwer Health

Massimo Volpe
Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort

Article • European Journal of Internal Medicine, January 2013, Elsevier

Massimo Volpe
Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation

Article • Clinical Medicine Insights Cardiology, January 2013, SAGE Publications

Massimo Volpe
Involvement of Health Professionals: From the General Practitioner to the Hypertension Specialist and the Hypertension Center

Article • January 2013, Springer Science + Business Media

Massimo Volpe
Plasma Renin and Cardiovascular Risk: What Is the Evidence for an Association?

Article • Cardiology, January 2013, Karger Publishers

Massimo Volpe
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

Article • New England Journal of Medicine, December 2012, New England Journal of Medicine (NEJM/MMS)

Dr Frederik Persson, Professor john j mcmurray, Massimo Volpe
Antihypertensive Efficacy of Olmesartan Medoxomil and Ramipril in Elderly Patients with Mild to Moderate Hypertension Grouped According to Renal Function Status

Article • High Blood Pressure & Cardiovascular Prevention, December 2012, Springer Science + Business Media

Prof. Stefano Omboni, Massimo Volpe
Renal Artery Denervation for Treating Resistant Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, December 2012, Springer Science + Business Media

Massimo Volpe
Cardiac Magnetic Resonance Evaluation of the Impact of Interventricular and Intraventricular Dyssynchrony on Cardiac Ventricular Systolic and Diastolic Function in Patients With Isolated Left Bundle Branch Block

Article • The American Journal of Cardiology, December 2012, Elsevier

Massimo Volpe
Sex differences in hypertension-related renal and cardiovascular diseases in Italy

Article • Journal of Hypertension, December 2012, Wolters Kluwer Health

Massimo Volpe
Omega-3 in Antiarrhythmic Therapy

Article • High Blood Pressure & Cardiovascular Prevention, December 2012, Springer Science + Business Media

Massimo Volpe
Triple combination therapy to improve blood pressure control: experience with olmesartan–amlodipine–hydrochlorothiazide therapy

Article • Expert Opinion on Pharmacotherapy, November 2012, Informa Healthcare

Massimo Volpe
Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome

Article • Drugs & Aging, November 2012, Springer Science + Business Media

Prof. Stefano Omboni, Massimo Volpe
QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly

Article • European Heart Journal, November 2012, European Society of Cardiology

Francesca Romana Pluchinotta, Massimo Volpe
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study

Article • Internal and Emergency Medicine, October 2012, Springer Science + Business Media

Massimo Volpe
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

Article • New England Journal of Medicine, October 2012, New England Journal of Medicine (NEJM/MMS)

Professor Antonis S Manolis, Professor Dmitry Zateyshchikov, Massimo Volpe
Global Cardiovascular Risk Management in Primary Prevention

Article • Current Vascular Pharmacology, October 2012, Bentham Science Publishers

Massimo Volpe
Shooting beyond score

Article • Journal of Hypertension, October 2012, Wolters Kluwer Health

Massimo Volpe
Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study

Article • Hypertension Research, September 2012, Springer Science + Business Media

Massimo Volpe
A Survey on Blood Pressure Levels and Hypertension Control in a Sample of the Italian General Population

Article • High Blood Pressure & Cardiovascular Prevention, September 2012, Springer Science + Business Media

Massimo Volpe
Pharmacological Modulation of Autophagy During Cardiac Stress

Article • Journal of Cardiovascular Pharmacology, September 2012, Wolters Kluwer Health

Massimo Volpe
Is reactivation of autophagy a possible therapeutic solution for obesity and metabolic syndrome?

Article • Autophagy, August 2012, Taylor & Francis

Massimo Volpe
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study

Article • Journal of the Renin-Angiotensin-Aldosterone System, August 2012, SAGE Publications

Massimo Volpe
Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination

Article • Clinical Drug Investigation, August 2012, Springer Science + Business Media

Massimo Volpe
Global cardiovascular risk management in different Italian regions: An analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational program

Article • Nutrition Metabolism and Cardiovascular Diseases, August 2012, Elsevier

Massimo Volpe
Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan

Article • Expert Review of Cardiovascular Therapy, August 2012, Taylor & Francis

Massimo Volpe
Gene Silencing of the Mitochondrial Adaptor p66 Shc Suppresses Vascular Hyperglycemic Memory in Diabetes

Article • Circulation Research, July 2012, Wolters Kluwer Health

Massimo Volpe
Non-Invasive Diagnostic Testing for Coronary Artery Disease in the Hypertensive Patient: Potential Advantages of a Risk Estimation-Based Algorithm

Article • American Journal of Hypertension, July 2012, Oxford University Press (OUP)

Massimo Volpe
Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients

Article • Journal of Hypertension, July 2012, Wolters Kluwer Health

Prof. Stefano Omboni, Massimo Volpe
Assessment of flow-mediated dilation reproducibility

Article • Journal of Hypertension, July 2012, Wolters Kluwer Health

Professor Giuseppe Ambrosio, Massimo Volpe
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design

Article • Journal of Human Hypertension, June 2012, Springer Science + Business Media

Massimo Volpe
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Article • Vascular Health and Risk Management, June 2012, Taylor & Francis

Giuliano Tocci, Massimo Volpe
An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients

Article • High Blood Pressure & Cardiovascular Prevention, June 2012, Springer Science + Business Media

Massimo Volpe
An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients

Article • High Blood Pressure & Cardiovascular Prevention, June 2012, Springer Science + Business Media

Massimo Volpe
Blood pressure control in Italy

Article • Journal of Hypertension, June 2012, Wolters Kluwer Health

Massimo Volpe
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation

Article • Journal of Hypertension, June 2012, Wolters Kluwer Health

Massimo Volpe
The clinical relevance of dysfunctional HDL in patients with coronary artery disease: A 3-year follow-up study

Article • International Journal of Cardiology, June 2012, Elsevier

Massimo Volpe
Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease

Article • Journal of the American College of Cardiology, May 2012, Elsevier

Professor Emanuele Barbato, Massimo Volpe
Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases

Article • International Journal of Cardiology, May 2012, Elsevier

Massimo Volpe
Increased temporal dispersion of myocardial repolarization in myotonic dystrophy Type 1

Article • International Journal of Cardiology, May 2012, Elsevier

Massimo Volpe
Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension

Article • Clinical Research in Cardiology, April 2012, Springer Science + Business Media

Dr Felix Mahfoud, Peter Bramlage, Massimo Volpe
Inhibition of the renin–angiotensin–aldosterone system

Article • Journal of Hypertension, April 2012, Wolters Kluwer Health

Massimo Volpe
Renin as a biomarker of cardiovascular disease in clinical practice

Article • Nutrition Metabolism and Cardiovascular Diseases, April 2012, Elsevier

Massimo Volpe
Rheb is a Critical Regulator of Autophagy During Myocardial Ischemia

Article • Circulation, March 2012, Wolters Kluwer Health

Massimo Volpe
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

Article • Integrated Blood Pressure Control, March 2012, Taylor & Francis

Massimo Volpe
NT-proANP circulating level is a prognostic marker in stable ischemic heart disease

Article • International Journal of Cardiology, March 2012, Elsevier

Professor Emanuele Barbato, Massimo Volpe
Population based strategy for dietary salt intake reduction: Italian initiatives in the European framework

Article • Nutrition Metabolism and Cardiovascular Diseases, March 2012, Elsevier

Massimo Volpe
The Changing Role of Hypertension Societies

Article • High Blood Pressure & Cardiovascular Prevention, March 2012, Springer Science + Business Media

Massimo Volpe
Pathophysiology of biventricular dysfunction during hemodialysis: Emerging concepts

Article • International Journal of Cardiology, March 2012, Elsevier

Massimo Volpe
Eplerenone works. Does it matter how?

Article • Expert Review of Cardiovascular Therapy, February 2012, Taylor & Francis

Massimo Volpe
Hypertension Control and Cardiometabolic Risk: A Regional Perspective

Article • Cardiology Research and Practice, January 2012, Hindawi Publishing Corporation

Peter Bramlage, Massimo Volpe
Angiotensin receptor blockers: clinical relevance and new opportunities

Article • Hot Topics in Hypertension, January 2012, FB Communication

Massimo Volpe
Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2012, De Gruyter

Massimo Volpe
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man

Article • Clinical Medicine Insights Cardiology, January 2012, SAGE Publications

Massimo Volpe
Use of aliskiren in a ‘real-life’ model of hypertension management

Article • Journal of Hypertension, January 2012, Wolters Kluwer Health

Massimo Volpe
Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels

Article • Nutrition Metabolism and Cardiovascular Diseases, December 2011, Elsevier

Massimo Volpe
Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure

Article • International Journal of Cardiology, December 2011, Elsevier

Massimo Volpe
Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?

Article • QJM, October 2011, Oxford University Press (OUP)

Massimo Volpe
Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: The AREA-in-CHF study

Article • Nutrition Metabolism and Cardiovascular Diseases, October 2011, Elsevier

Massimo Volpe
Relation between serum sodium levels and prognosis in outpatients with chronic heart failure

Article • Journal of Cardiovascular Medicine, October 2011, Wolters Kluwer Health

Massimo Volpe
Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort

Article • International Journal of Cardiology, October 2011, Elsevier

Massimo Volpe
Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials

Article • American Journal of Hypertension, October 2011, Oxford University Press (OUP)

Massimo Volpe
Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH

Article • European Journal of Preventive Cardiology, September 2011, SAGE Publications

Peter Bramlage, Massimo Volpe
Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program

Article • Clinical Cardiology, September 2011, Wiley

Massimo Volpe
Modern Clinical Management of Arterial Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, September 2011, Springer Science + Business Media

Massimo Volpe
Direct Renin Inhibition

Article • High Blood Pressure & Cardiovascular Prevention, September 2011, Springer Science + Business Media

Massimo Volpe
Is there any memory effect of blood pressure lowering in diabetes?

Article • International Journal of Cardiology, September 2011, Elsevier

Massimo Volpe
Angiotensin receptor modulation and cardiovascular remodeling

Article • Journal of the Renin-Angiotensin-Aldosterone System, August 2011, SAGE Publications

Massimo Volpe
Unexpectedly low mutation rates in beta‐myosin heavy chain and cardiac myosin binding protein genes in italian patients with hypertrophic cardiomyopathy

Article • Journal of Cellular Physiology, August 2011, Wiley

Massimo Volpe
Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion

Article • Circulation Research, August 2011, Wolters Kluwer Health

Massimo Volpe
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides

Article • Journal of Molecular Medicine, August 2011, Springer Science + Business Media

Massimo Volpe
Aminoterminal natriuretic peptide as a determinant of PAI‐1 levels in a sample of the adult male Italian population

Article • Journal of Thrombosis and Haemostasis, August 2011, Elsevier

Massimo Volpe
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy

Article • Expert Review of Cardiovascular Therapy, July 2011, Taylor & Francis

Massimo Volpe
Hyperbaric oxygen therapy in a case of cholesterol crystal embolization

Article • The American Journal of Emergency Medicine, July 2011, Elsevier

Massimo Volpe
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice

Article • Clinical and Experimental Hypertension, June 2011, Taylor & Francis

Massimo Volpe
Prevalence of ‘Borderline’ Values of Cardiovascular Risk Factors in the Clinical Practice of General Medicine in Italy

Article • High Blood Pressure & Cardiovascular Prevention, June 2011, Springer Science + Business Media

Professor Cristina Giannattasio, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention is now on MEDLINE

Article • High Blood Pressure & Cardiovascular Prevention, June 2011, Springer Science + Business Media

Massimo Volpe
Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease

Article • International Journal of Cardiology, June 2011, Elsevier

Massimo Volpe
Impact of physicians’ age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme

Article • International Journal of Clinical Practice, May 2011, Hindawi Publishing Corporation

Massimo Volpe
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

Article • American Journal of Hypertension, May 2011, Oxford University Press (OUP)

Massimo Volpe
End-Organ Protection in Patients with Hypertension

Article • Drugs, May 2011, Springer Science + Business Media

Massimo Volpe
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study

Article • Journal of Nephrology, April 2011, SAGE Publications

Massimo Volpe
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade

Article • Current Hypertension Reports, April 2011, Springer Science + Business Media

Massimo Volpe
Antihypertensive Treatment and Development of Heart Failure in Hypertension

Article • Archives of Internal Medicine, March 2011, American Medical Association (AMA)

Massimo Volpe
Network Meta-analysis of Heart Failure Prevention by Antihypertensive Drugs—Reply

Article • Archives of Internal Medicine, March 2011, American Medical Association (AMA)

Massimo Volpe
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice

Article • Blood Pressure, March 2011, Taylor & Francis

Massimo Volpe
Olmesartan medoxomil for the treatment of hypertension in children and adolescents

Article • Vascular Health and Risk Management, March 2011, Taylor & Francis

Giuliano Tocci, Massimo Volpe
An Analysis of the Management of Cardiovascular Risk Factors in Routine Clinical Practice in Italy

Article • High Blood Pressure & Cardiovascular Prevention, March 2011, Springer Science + Business Media

Massimo Volpe
2010 Position Paper of the Italian Society of Hypertension (SIIA)

Article • High Blood Pressure & Cardiovascular Prevention, March 2011, Springer Science + Business Media

Massimo Volpe
Angiotensin type 2 receptor in hypertensive cardiovascular disease

Article • Current Opinion in Nephrology & Hypertension, March 2011, Wolters Kluwer Health

Massimo Volpe
Chronic Kidney Disease in the Hypertensive Patient

Article • High Blood Pressure & Cardiovascular Prevention, March 2011, Springer Science + Business Media

Massimo Volpe
Reply

Article • Nephrology Dialysis Transplantation, February 2011, Oxford University Press (OUP)

Massimo Volpe
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study)

Article • Journal of Hypertension, February 2011, Wolters Kluwer Health

Massimo Volpe
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy

Article • Clinical Science, January 2011, Portland Press Ltd.

Massimo Volpe
Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing

Article • Sleep And Breathing, January 2011, Springer Science + Business Media

Massimo Volpe
Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension

Article • International Journal of Hypertension, January 2011, Hindawi Publishing Corporation

Massimo Volpe
2009 SIPREC Consensus Document – Executive Summary

Article • High Blood Pressure & Cardiovascular Prevention, December 2010, Springer Science + Business Media

Massimo Volpe
Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure

Article • International Journal of Cardiology, December 2010, Elsevier

Massimo Volpe
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study

Article • Journal of Hypertension, November 2010, Wolters Kluwer Health

Prof. Stefano Omboni, Massimo Volpe
Prediction of Long‐Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15‐Year Prospective Follow‐Up Study

Article • Clinical Cardiology, November 2010, Wiley

Massimo Volpe
Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancer

Article • European Heart Journal, October 2010, European Society of Cardiology

Massimo Volpe
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial

Article • Heart, October 2010, BMJ

Massimo Volpe
Erythropoietin and the heart: facts and perspectives

Article • Clinical Science, September 2010, Portland Press Ltd.

Massimo Volpe
NT-proANP/ANP is a Determinant of Vascular Damage in Humans

Article • High Blood Pressure & Cardiovascular Prevention, September 2010, Springer Science + Business Media

Massimo Volpe
Rethinking targets of blood pressure and guidelines for hypertension clinical management

Article • Nephrology Dialysis Transplantation, August 2010, Oxford University Press (OUP)

Massimo Volpe
Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy

Article • Journal of Hypertension, August 2010, Wolters Kluwer Health

Massimo Volpe
No association between chromosome 12p13 single nucleotide polymorphisms and early‐onset ischemic stroke

Article • Journal of Thrombosis and Haemostasis, August 2010, Elsevier

Massimo Volpe
Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH

Article • Clinical Research in Cardiology, July 2010, Springer Science + Business Media

Massimo Volpe
NPR-C: a component of the natriuretic peptide family with implications in human diseases

Article • Journal of Molecular Medicine, June 2010, Springer Science + Business Media

Massimo Volpe
Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance

Article • High Blood Pressure & Cardiovascular Prevention, June 2010, Springer Science + Business Media

Massimo Volpe
Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice

Article • Expert Review of Cardiovascular Therapy, June 2010, Taylor & Francis

Massimo Volpe
A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients

Article • Journal of Clinical Hypertension, May 2010, Wiley

Peter Bramlage, Massimo Volpe
Letter by Assenza et al Regarding Article, “Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia”

Article • Circulation, May 2010, Wolters Kluwer Health

Massimo Volpe
The cardiovascular continuum refined: A hypothesis

Article • Blood Pressure, May 2010, Taylor & Francis

Massimo Volpe
Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction

Article • Journal of Clinical Hypertension, April 2010, Wiley

Massimo Volpe
Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy

Article • Heart, March 2010, BMJ

Massimo Volpe
Use of Electronic Support for Implementing Global Cardiovascular Risk Management

Article • High Blood Pressure & Cardiovascular Prevention, March 2010, Springer Science + Business Media

Massimo Volpe
Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study

Article • Journal of Hypertension, February 2010, Wolters Kluwer Health

Massimo Volpe
The challenge of polypharmacy in cardiovascular medicine

Article • Fundamental and Clinical Pharmacology, January 2010, Wiley

Massimo Volpe
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study

Article • Journal of Hypertension, January 2010, Wolters Kluwer Health

Massimo Volpe
Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism

Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

Massimo Volpe
Right Ventricular Dysfunction in Patients with End-Stage Renal Disease

Article • American Journal of Nephrology, January 2010, Karger Publishers

Massimo Volpe
Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine

Article • European Journal of Cardiovascular Prevention & Rehabilitation, December 2009, SAGE Publications

Massimo Volpe
Extracellular Matrix Remodelling in Myocardial Hypertrophy and Failure

Article • High Blood Pressure & Cardiovascular Prevention, December 2009, Springer Science + Business Media

Massimo Volpe
Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications

Article • Clinical Science, November 2009, Portland Press Ltd.

Massimo Volpe
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

Article • The Lancet, November 2009, Elsevier

Professor Antonis S Manolis, Massimo Volpe
Modern cardiovascular risk management in clinical practice

Article • Hipertensión y Riesgo Vascular, November 2009, Elsevier

Massimo Volpe
Alzheimer’s disease and endothelial dysfunction

Article • Neurological Sciences, October 2009, Springer Science + Business Media

Massimo Volpe
Antihypertensive drug therapy and blood pressure control in men and women: an international perspective

Article • Journal of Human Hypertension, October 2009, Springer Science + Business Media

Massimo Volpe
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Article • New England Journal of Medicine, September 2009, New England Journal of Medicine (NEJM/MMS)

Professor Philippe Gabriel STEG, Professor Antonis S Manolis, Professor Dmitry Zateyshchikov, Massimo Volpe
Human coronary atherosclerosis modulates cardiac natriuretic peptide release

Article • Atherosclerosis, September 2009, Elsevier

Professor Emanuele Barbato, Massimo Volpe
Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro

Article • Journal of Hypertension, September 2009, Wolters Kluwer Health

Massimo Volpe
A case of thrombolysis in acute pulmonary embolism with right atrial thrombus: comparing current and past guidelines

Article • Internal and Emergency Medicine, August 2009, Springer Science + Business Media

Massimo Volpe
European Perspectives

Article • Circulation, August 2009, Wolters Kluwer Health

Massimo Volpe
Can primary care professionals’ adherence to Evidence Based Medicine tools improve quality of care in Type 2 diabetes mellitus? A systematic review

Article • Diabetes Research and Clinical Practice, August 2009, Elsevier

Massimo Volpe
p66Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link

Article • Journal of Molecular Medicine, July 2009, Springer Science + Business Media

Massimo Volpe
Nationwide Trends in Hospitalization and Surgical Treatment of Congenital and Infantile Cataract Among Italian Children 4 Years and Younger

Article • Journal of Pediatric Ophthalmology & Strabismus, July 2009, SLACK, Inc.

Massimo Volpe
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

Article • Journal of Thrombosis and Thrombolysis, June 2009, Springer Science + Business Media

Massimo Volpe
Global Cardiovascular Risk Assessment in Different Clinical Settings

Article • High Blood Pressure & Cardiovascular Prevention, June 2009, Springer Science + Business Media

Massimo Volpe
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept

Article • Journal of Hypertension, June 2009, Wolters Kluwer Health

Massimo Volpe
Bridging science and health policy in cardiovascular disease: focus on lipid management

Article • Atherosclerosis Supplements, June 2009, Elsevier

Massimo Volpe
The Myth of Janus

Article • High Blood Pressure & Cardiovascular Prevention, June 2009, Springer Science + Business Media

Massimo Volpe
Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians

Article • European Journal of Human Genetics, May 2009, Springer Science + Business Media

Massimo Volpe
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials

Article • Journal of Hypertension, May 2009, Wolters Kluwer Health

Massimo Volpe
Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension

Article • Clinical Drug Investigation, May 2009, Springer Science + Business Media

Massimo Volpe
TRANSCEND Aftermath

Article • High Blood Pressure & Cardiovascular Prevention, May 2009, Springer Science + Business Media

Massimo Volpe
Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure

Article • European Heart Journal, April 2009, European Society of Cardiology

Massimo Volpe
Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients

Article • European Heart Journal, April 2009, European Society of Cardiology

Peter Bramlage, Massimo Volpe
Valsartan for Prevention of Recurrent Atrial Fibrillation

Article • New England Journal of Medicine, April 2009, New England Journal of Medicine (NEJM/MMS)

Massimo Volpe
Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction

Article • American Journal of Hypertension, April 2009, Oxford University Press (OUP)

Massimo Volpe
Cardiopulmonary exercise testing in heart failure: from ugly duckling to swan

Article • Internal and Emergency Medicine, March 2009, Springer Science + Business Media

Massimo Volpe
Role of the renin–angiotensin–aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction

Article • Clinical Science, February 2009, Portland Press Ltd.

Massimo Volpe
Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine

Article • Expert Review of Cardiovascular Therapy, February 2009, Taylor & Francis

Massimo Volpe
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Dise...

Article • Journal of Hypertension, February 2009, Wolters Kluwer Health

Massimo Volpe
Management of hypertension and stroke prevention: results of the Italian cardiologist survey

Article • International Journal of Clinical Practice, February 2009, Hindawi Publishing Corporation

Massimo Volpe
Anti‐remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN‐CHF study): final results

Article • European Journal of Heart Failure, January 2009, Wiley

Massimo Volpe
Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy

Article • Clinical Drug Investigation, January 2009, Springer Science + Business Media

Massimo Volpe
Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects

Article • Stroke, January 2009, Wolters Kluwer Health

Massimo Volpe
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Article • New England Journal of Medicine, December 2008, New England Journal of Medicine (NEJM/MMS)

Professor john j mcmurray, Professor Thierry C Gillebert, Professor Thomas Munzel or Muenzel, Massimo Volpe
Inhibition of Protein Kinase Cβ Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages

Article • Circulation, November 2008, Wolters Kluwer Health

Massimo Volpe
Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?

Article • Cardiovascular & Hematological Agents in Medicinal Chemistry, October 2008, Bentham Science Publishers

Massimo Volpe
Effort angina in a patient with advanced coronary artery disease. Role played by coronary angiography, Ivus and cardiac CT: case report

Article • Cardiovascular Ultrasound, September 2008, Springer Science + Business Media

Massimo Volpe
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Article • The Lancet, September 2008, Elsevier

Professor Thomas Munzel or Muenzel, Massimo Volpe
Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study

Article • Journal of Hypertension, September 2008, Wolters Kluwer Health

Massimo Volpe
Managing hypertension in cardiology practice according to risk profile

Article • International Journal of Clinical Practice, July 2008, Hindawi Publishing Corporation

Massimo Volpe
Development of heart failure in recent hypertension trials

Article • Journal of Hypertension, July 2008, Wolters Kluwer Health

Massimo Volpe
Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases

Article • American Journal of Hypertension, July 2008, Oxford University Press (OUP)

Massimo Volpe
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

Article • New England Journal of Medicine, April 2008, New England Journal of Medicine (NEJM/MMS)

Professor Thomas Munzel or Muenzel, Massimo Volpe
Final Common Molecular Pathways of Aging and Cardiovascular Disease

Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2008, Wolters Kluwer Health

Massimo Volpe
Coronary artery fistula from the circumflex artery to the left atrium: invasive and non-invasive imaging techniques

Article • Journal of Cardiovascular Medicine, March 2008, Wolters Kluwer Health

Massimo Volpe
Non-pharmacological control of plasma cholesterol levels

Article • Nutrition Metabolism and Cardiovascular Diseases, February 2008, Elsevier

Dr Arrigo FG CICERO, Massimo Volpe
A New Option for Therapeutic Management of Patients with Cerebrovascular Disease

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH

Article • Journal of Hypertension, January 2008, Wolters Kluwer Health

Peter Bramlage, Massimo Volpe
Highlights from International Congress

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
2008 White Paper for Implementing Strategies and Interventions for Cardiovascular Prevention in Italy

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
A New Option for Therapeutic Management of Patients with Cardiovascular Disease

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Antihypertensive efficacy and tolerability of candesartan–hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy

Article • Blood Pressure, January 2008, Taylor & Francis

Massimo Volpe
Arterial Hypertension and Cardiac Damage

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Cardiovascular Risk in Hypertension – Can We Ask for More?

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Cardiovascular Risk Management in Clinical Practice

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Overview of the i-SEARCH Global Study

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Pulsatile Stretch Induces Release of Angiotensin II and Oxidative Stress in Human Endothelial Cells: Effects of ACE Inhibition and AT1 Receptor Antagonism

Article • Clinical and Experimental Hypertension, January 2008, Taylor & Francis

Massimo Volpe
The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements

Article • Blood Pressure, January 2008, Taylor & Francis

Massimo Volpe
Vascular Senescence at the Crossroad between Oxidative Stress and Nitric Oxide Pathways

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
β-Blockers and Diuretics in the Treatment of Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

Massimo Volpe
Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy

Article • Journal of Hypertension, December 2007, Wolters Kluwer Health

Massimo Volpe
Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study

Article • Journal of Hypertension, November 2007, Wolters Kluwer Health

Peter Bramlage, Massimo Volpe
Justificación de la terapia combinada con IECA y bloqueadores de los canales de calcio en la hipertensión

Article • Hipertensión, November 2007, Elsevier

Massimo Volpe
Microalbuminuria screening in patients with hypertension: recommendations for clinical practice

Article • International Journal of Clinical Practice, October 2007, Hindawi Publishing Corporation

Massimo Volpe
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia

Article • Heart, October 2007, BMJ

Massimo Volpe
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents

Article • Journal of Applied Physiology, October 2007, American Physiological Society

Professor fabio naro, Massimo Volpe
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study

Article • Journal of Hypertension, October 2007, Wolters Kluwer Health

Massimo Volpe
Managing cardiovascular risk: the need for change

Article • Journal of Human Hypertension, September 2007, Springer Science + Business Media

Massimo Volpe
A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians

Article • Journal of Internal Medicine, August 2007, Wiley

Massimo Volpe
Evaluation of Intermediate Endpoints: Clinical Implications in the Management of Arterial Hypertension

Article • Current Hypertension Reviews, August 2007, Bentham Science Publishers

Massimo Volpe
Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension

Article • Expert Review of Cardiovascular Therapy, July 2007, Taylor & Francis

Massimo Volpe
Blood pressure control in Italy: results of recent surveys on hypertension

Article • Journal of Hypertension, July 2007, Wolters Kluwer Health

Massimo Volpe
Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome

Article • American Journal of Hypertension, July 2007, Oxford University Press (OUP)

Massimo Volpe
Use of Predictive Markers to Improve Cardiovascular Protection

Article • Future Cardiology, July 2007, Taylor & Francis

Massimo Volpe
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Article • European Heart Journal Supplements, June 2007, Oxford University Press (OUP)

Massimo Volpe
β2-Adrenergic Receptor Gene Polymorphisms and Risk of Ischemic Stroke

Article • American Journal of Hypertension, June 2007, Oxford University Press (OUP)

Massimo Volpe
Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans

Article • Journal of Human Hypertension, May 2007, Springer Science + Business Media

Massimo Volpe
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual

Article • Journal of Hypertension, May 2007, Wolters Kluwer Health

Massimo Volpe
Letter by Conti and Volpe Regarding Article, “Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium”

Article • Circulation, April 2007, Wolters Kluwer Health

Massimo Volpe
Restoring the Dysfunctional Endothelium

Article • Current Pharmaceutical Design, April 2007, Bentham Science Publishers

Massimo Volpe
Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

Article • Journal of Hypertension, April 2007, Wolters Kluwer Health

Massimo Volpe
Genetic deletion of p66 Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress

Article • Proceedings of the National Academy of Sciences, March 2007, Proceedings of the National Academy of Sciences

Massimo Volpe
The PlA1/A2 polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients

Article • Journal of Hypertension, March 2007, Wolters Kluwer Health

Gaetano Santulli, Massimo Volpe
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin

Article • European Journal of Heart Failure, March 2007, Wiley

Massimo Volpe
Left bundle‐branch block—pathophysiology, prognosis, and clinical management

Article • Clinical Cardiology, March 2007, Wiley

Massimo Volpe
Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients

Article • Hypertension, February 2007, Wolters Kluwer Health

Massimo Volpe
Arterial Stiffness and Cognitive Impairment in the Elderly

Article • High Blood Pressure & Cardiovascular Prevention, January 2007, Springer Science + Business Media

Massimo Volpe
High Blood Pressure & Cardiovascular Prevention

Article • High Blood Pressure & Cardiovascular Prevention, January 2007, Springer Science + Business Media

Massimo Volpe
The Role of Arterial Stiffness in Stratifying the Overall Cardiovascular Risk

Article • High Blood Pressure & Cardiovascular Prevention, January 2007, Springer Science + Business Media

Massimo Volpe
Nitric Oxide Release Is Impaired in Hypertensive Individuals With Familial History of Stroke

Article • American Journal of Hypertension, December 2006, Oxford University Press (OUP)

Massimo Volpe
Reciprocal congenic lines for a major stroke QTL on rat chromosome 1

Article • Physiological Genomics, October 2006, American Physiological Society

Massimo Volpe
Antihypertensive therapy and cerebrovascular protection

Article • Current Opinion in Nephrology & Hypertension, September 2006, Wolters Kluwer Health

Massimo Volpe
Association of Atrial Natriuretic Peptide and Type A Natriuretic Peptide Receptor Gene Polymorphisms With Left Ventricular Mass in Human Essential Hypertension

Article • Journal of the American College of Cardiology, August 2006, Elsevier

Massimo Volpe
Angiotensin receptor blockers and myocardial infarction: the importance of dosage

Article • Journal of Hypertension, August 2006, Wolters Kluwer Health

Massimo Volpe
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Article • European Heart Journal, June 2006, European Society of Cardiology

Massimo Volpe
Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies

Article • Current Medical Research and Opinion, June 2006, Taylor & Francis

Massimo Volpe
Fewer Mega-Trials and More Clinically Oriented Studies in Hypertension Research? The Case of Blocking the Renin-Angiotensin-Aldosterone System

Article • Journal of the American Society of Nephrology, April 2006, Wolters Kluwer Health

Massimo Volpe
Metabolic Syndrome

Article • High Blood Pressure & Cardiovascular Prevention, January 2006, Springer Science + Business Media

Massimo Volpe
The Apelin/APJ System

Article • High Blood Pressure & Cardiovascular Prevention, January 2006, Springer Science + Business Media

Massimo Volpe
Treatment of High-Risk Hypertensive Patients

Article • High Blood Pressure & Cardiovascular Prevention, January 2006, Springer Science + Business Media

Massimo Volpe
A role of TNF‐α gene variant on juvenile ischemic stroke: a case–control study

Article • European Journal of Neurology, November 2005, Wiley

Massimo Volpe
Angiotensin II receptor blockers and coronary artery disease: 'presumed innocents'

Article • European Heart Journal, October 2005, European Society of Cardiology

Massimo Volpe
Pregnancy-Associated Plasma Protein-A and Acute Coronary Syndromes: Cause or Consequence?

Article • Journal of the American College of Cardiology, October 2005, Elsevier

Massimo Volpe
Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure

Article • Blood, September 2005, American Society of Hematology

Massimo Volpe
Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

Article • International Journal of Cardiology, July 2005, Elsevier

Massimo Volpe
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists

Article • American Journal of Hypertension, April 2005, Oxford University Press (OUP)

Massimo Volpe
Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Article • Journal of Human Hypertension, March 2005, Springer Science + Business Media

Massimo Volpe
A Novel Molecule of the Angiotensin II Receptor Blocker Class

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection

Article • Blood Pressure, January 2005, Taylor & Francis

Massimo Volpe
Head-to-Head Intervention Trials in Hypertension

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
Natriuretic Peptides

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population

Article • Thrombosis and Haemostasis, January 2005, Thieme Publishing Group

Massimo Volpe
Similarities and Differences in Hypertension Guidelines

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
Treating Hypertension with Angiotensin II Receptor Blockers

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
What Should We Expect from the Next Guidelines on Hypertension?

Article • High Blood Pressure & Cardiovascular Prevention, January 2005, Springer Science + Business Media

Massimo Volpe
Deletion of p66 shc Gene Protects Against Age-Related Endothelial Dysfunction

Article • Circulation, November 2004, Wolters Kluwer Health

Massimo Volpe
Article • American Journal of Hypertension, November 2004, Oxford University Press (OUP)

Massimo Volpe
Gene polymorphisms of the renin???angiotensin???aldosterone system and the risk of ischemic stroke

Article • Journal of Hypertension, November 2004, Wolters Kluwer Health

Massimo Volpe
The case for blood pressure control in risk groups

Article • International Journal of Clinical Practice, October 2004, Hindawi Publishing Corporation

Massimo Volpe
Insulin-Like Growth Factor-1 as a Vascular Protective Factor

Article • Circulation, October 2004, Wolters Kluwer Health

Massimo Volpe
Role of Genetic Factors in the Etiopathogenesis of Cerebrovascular Accidents: From an Animal Model to the Human Disease

Article • Cellular and Molecular Neurobiology, October 2004, Springer Science + Business Media

Massimo Volpe
Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists

Article • Journal of Human Hypertension, September 2004, Springer Science + Business Media

Massimo Volpe
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS)

Article • Journal of Human Hypertension, July 2004, Springer Science + Business Media

Massimo Volpe
Selective Inhibition of Protein Kinase Cβ 2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Article • Circulation, July 2004, Wolters Kluwer Health

Massimo Volpe
Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey

Article • Current Medical Research and Opinion, June 2004, Informa Healthcare

Massimo Volpe
Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans

Article • Stroke, April 2004, Wolters Kluwer Health

Massimo Volpe
In the search for stroke genes: a long and winding road

Article • American Journal of Hypertension, February 2004, Oxford University Press (OUP)

Massimo Volpe
Hypertension and Heart Failure: Role of Neurohormonal Mechanisms

Article • Clinical and Experimental Hypertension, January 2004, Taylor & Francis

Massimo Volpe
Genetic polymorphism of the renin???angiotensin???aldosterone system and arterial hypertension in the Italian population

Article • Journal of Hypertension, October 2003, Wolters Kluwer Health

Prof. Carmine Zoccali, Massimo Volpe
Contribution of Genetic Factors to Renal Lesions in the Stroke-Prone Spontaneously Hypertensive Rat

Article • Hypertension, October 2003, Wolters Kluwer Health

Massimo Volpe
Angiotensin II AT2 receptor subtype

Article • Journal of Hypertension, August 2003, Wolters Kluwer Health

Massimo Volpe
Hypertension guidelines: criteria that might make them more clinically useful

Article • American Journal of Hypertension, August 2003, Oxford University Press (OUP)

Massimo Volpe
Is it time to measure microalbuminuria in hypertension?

Article • Journal of Hypertension, July 2003, Wolters Kluwer Health

Massimo Volpe
Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension

Article • Clinical Therapeutics, May 2003, Elsevier

Massimo Volpe
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy

Article • Journal of Hypertension, March 2003, Wolters Kluwer Health

Massimo Volpe
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells

Article • Circulation, February 2003, Wolters Kluwer Health

Massimo Volpe
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor

Article • Biochemical Journal, February 2003, Portland Press Ltd.

Massimo Volpe
Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats

Article • Journal of Hypertension, January 2003, Wolters Kluwer Health

Massimo Volpe
In memoriam

Article • Journal of Hypertension, December 2002, Wolters Kluwer Health

Massimo Volpe
Hypertension guidelines: criteria that might make them more clinically useful

Article • American Journal of Hypertension, October 2002, Oxford University Press (OUP)

Massimo Volpe
Antihypertensive effect and end-organ protection of flavonoids: some insights, more questions

Article • Journal of Hypertension, September 2002, Wolters Kluwer Health

Massimo Volpe
Ace inhibition and cardiovascular mortality and morbidity in essential hypertension: The end of the search or a need for further investigations?

Article • American Journal of Hypertension, April 2002, Oxford University Press (OUP)

Massimo Volpe
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts

Article • Journal of Hypertension, April 2002, Wolters Kluwer Health

Massimo Volpe
Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription

Article • Peptides, March 2002, Elsevier

Massimo Volpe
Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic β1-selective receptor blockade

Article • Journal of Hypertension, March 2002, Wolters Kluwer Health

Massimo Volpe
The atrial natriuretic peptide: a changing view

Article • Journal of Hypertension, November 2001, Wolters Kluwer Health

Massimo Volpe
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy

Article • European Heart Journal, August 2001, European Society of Cardiology

Massimo Volpe
Differential Regulation of Epstein-Barr Virus (EBV) Latent Gene Expression in Burkitt Lymphoma Cells Infected with a Recombinant EBV Strain

Article • Journal of Virology, May 2001, ASM Journals

Massimo Volpe
Etiology and pathophysiology of stroke as a complex trait

Article • American Journal of Hypertension, October 2000, Oxford University Press (OUP)

Massimo Volpe
Characterization of caveolae from rat heart: Localization of postreceptor signal transduction molecules and their rearrangement after norepinephrine stimulation

Article • Journal of Cellular Biochemistry, June 2000, Wiley

Massimo Volpe
Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat

Article • Basic Research in Cardiology, April 2000, Springer Science + Business Media

Massimo Volpe
Role of angiotensin II AT 1 and AT 2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats

Article • Basic Research in Cardiology, February 2000, Springer Science + Business Media

Massimo Volpe
Abnormalities of Endothelial Function in the Pathogenesis of Stroke: The Importance of Endothelin

Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

Massimo Volpe
Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure

Article • American Heart Journal, August 1999, Elsevier

Massimo Volpe
Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats

Article • Journal of Hypertension, December 1998, Wolters Kluwer Health

Massimo Volpe
Long-term effects of felodipine in patients with mild heart failure treated chronically with enalapril: a randomized, placebo-controlled study

Article • Current Therapeutic Research, May 1998, Elsevier

Massimo Volpe
Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats

Article • Journal of Hypertension, February 1998, Wolters Kluwer Health

Massimo Volpe
Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease

Article • Nature Genetics, August 1996, Springer Science + Business Media

Massimo Volpe
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure

Article • The American Journal of Cardiology, March 1996, Elsevier

Massimo Volpe
Transition from asymptomatic left ventricular dysfunction to congestive heart failure

Article • Journal of Cardiac Failure, December 1995, Elsevier

Massimo Volpe
Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients

Article • The American Journal of Cardiology, December 1994, Elsevier

Massimo Volpe
Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles

Article • The American Journal of Cardiology, September 1994, Elsevier

Massimo Volpe
Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril

Article • The American Journal of Cardiology, October 1992, Elsevier

Massimo Volpe
Effect of complete cardiac denervation on atrial natriuretic factor release in baboons

Article • Journal of Surgical Research, July 1992, Elsevier

Massimo Volpe
Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study

Article • European Journal of Nuclear Medicine and Molecular Imaging, January 1991, Springer Science + Business Media

Massimo Volpe
Cardiopulmonary receptors and coronary circulation

Article • Journal of the Autonomic Nervous System, July 1990, Elsevier

Massimo Volpe
Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function

Article • The American Journal of Cardiology, February 1989, Elsevier

Massimo Volpe
Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy

Article • The American Journal of Cardiology, October 1988, Elsevier

Massimo Volpe
Reflex control of coronary vascular tone by cardiopulmonary receptors in humans

Article • Journal of the American College of Cardiology, May 1988, Elsevier

Massimo Volpe
Beta blockers and left ventricular hypertrophy in hypertension

Article • American Heart Journal, October 1987, Elsevier

Massimo Volpe
Effects of atrial natriuretic factor on human platelet function

Article • Life Sciences, October 1985, Elsevier

Massimo Volpe
Role of prostaglandins in the renal handling of a salt load in essential hypertension

Article • The American Journal of Cardiology, January 1985, Elsevier

Massimo Volpe
Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension

Article • The American Journal of Cardiology, March 1984, Elsevier

Massimo Volpe
Renal Function in Borderline Hypertensive First-Degree Relatives of Essential Hypertensives

Article • Cardiology, January 1982, Karger Publishers

Massimo Volpe
EFFECTS OF GUANETHIDINE ON HISTAMINE RELEASE DURING REFLEX VASODILATATION IN THE DOG

Article • British Journal of Pharmacology, July 1977, Wiley

Massimo Volpe

Search

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

All Stories